Clinical Trial Diversification

The Clinical Trial Diversification Initiative has achieved its goal of developing better practice materials for site and sponsors to improve engagement and recruitment of minority patient populations.

Rationale

Minority patients have often been underrepresented in clinical trials. Despite various safety, clinical, regulatory, commercial and ethical needs to increase the representativeness of trials, study teams are often unaware of the need for diversity and the resources available to improve the recruitment and retention rates of racially and ethnically diverse populations.

A broader recognition of the benefits and techniques of improving diversity in clinical trials is needed. TransCelerate’s Clinical Trial Diversification Initiative enhances the racial and ethnic diversity of clinical trial populations by helping sponsors achieve trials that are representative of the indicated population.

Benefits

The Clinical Trial Diversification Initiative has developed sponsor and clinical trial site guidance on better practices and processes for minority recruitment. The guidance focuses on six key areas, including diversity awareness, patient engagement, cultural competency, reimbursement IRB insights, informed consent and community engagement.

Available Solutions

The Clinical Trial Diversification Initiative has developed sponsor and clinical trial site guidance on better practices and processes for minority recruitment. The guidance focuses on six key areas.

Similar Initiatives

Pediatric Trial Efficiencies

The Pediatric Efficiencies Initiative thoroughly assessed potential solutions that would lead to faster access to new drugs for pediatric patients. Rather than continue as a standalone initiative, we will transition the focal points of pediatric populations across the broader TransCelerate portfolio, where appropriate.

eLabels

The eLabels Initiative will support TransCelerate Member Companies in establishing an innovative information channel: Electronic Labels (eLabels). This initiative will work to enhance label utility for patients.

Historical Trial Data Sharing

The Historical Trial Data Sharing (Controls) Initiative was established to enable the sharing of data to maximize the value of clinical data collected historically in the placebo and standard of care control arms of clinical trials.